Skip to main content

Our Board

Our board members bring extensive experience across the Australian healthcare and medical sector, and biotechnology industry.

Matt O’Keefe

Matt O’Keefe

Matt O’Keefe is a Board Director of the Peter MacCallum Cancer Centre and the Chairman of the Finance Committee. With more than 25 years’ technology, finance and assurance experience, he specialises in technology advisory and offers numerous services across technology governance and risk, project management, and more.

Deirdre Blythe

Deirdre experience includes Chief Operating Officer at Arts Centre Melbourne where her responsibilities include Finance, IT and digital, Facilities Management, Strategic Planning, Risk Management and more. Deirdre was on the Peter MacCallum Cancer Centre Board until July 2032, and is Chair of the Audit and Risk Management Committee. 

Libby Secomb

With over 20 years’ experience, Libby is a Finance professional with a demonstrated history of working in the financial services industry. She is skilled in operational leadership, Financial Risk, Internal Audit, Risk Management, and Corporate Finance. Before her successful career as a finance and accounting professional, Libby was a medical laboratory scientist at the Royal Children’s Hospital. 

Michelle Burke
Non-Executive Director
Michelle has Board and Executive experience in the pharmaceuticals and biotechnology sector. She served for nine years as Non-Executive Director and recently as Chair of AusBiotech Ltd. She is a member of Pharmaceutical Benefits Advisory Committee (PBAC) and of the Strategic Advisory Group of the Australian Brain Cancer Mission.

Behind the Scenes

Cell Therapies is led and supported by an extensive team of experts from across the medical, healthcare and scientific communities to drive the development and commercialization of groundbreaking cell and gene therapies.

Leadership Team

Dedicated and experienced cell and gene therapy experts driving your product from clinical trial to commercial supply

Scientific Advisors

Expertise and knowledge across cell and gene therapies as well as the health and medical sector